1. Home
  2. Labeler Index
  3. Pd-rx Pharmaceuticals, Inc.
  4. 43063-832
  5. Product Images: Spironolactone

Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Spironolactone NDC 43063-832 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

43063832 Label - 43063832

43063832 Label - 43063832

The text is a description of a medication called Spironolactone, which comes in film-coated 25 mg tablets. There are three bottles of 30 tablets each, all with the same lot number and expiration date. Patients should take the tablet(s) as directed by their doctor and may experience side effects, which they can report to the FDA. The tablets are yellow, round, and marked with the identifier of the pharmaceutical company that manufactured them. There are also barcodes with product information. The rest of the text appears to be errors generated by and is not useful.*

Figure 1. Survival by Treatment Group in The Randomized Spironolactone Evaluation Study - spironolactone figure 1

Figure 1. Survival by Treatment Group in The Randomized Spironolactone Evaluation Study - spironolactone figure 1

This appears to be a partial output of a statistical analysis report showing a p-value result for a log-rank test. It also includes a time frame in months ranging from 12 to 48. However, without more context or complete information, it is difficult to provide a meaningful description.*

Figure 2. Hazard Ratios of All-Cause Mortality by Subgroup in The Randomized Spironolactone Evaluation Study - spironolactone figure 2

Figure 2. Hazard Ratios of All-Cause Mortality by Subgroup in The Randomized Spironolactone Evaluation Study - spironolactone figure 2

This is a chart or table showing the results of a subgroup analysis comparing the efficacy of spironolactone versus placebo. The data is presented in a horizontal bar graph format with values on the y-axis ranging from 0 to 5. The x-axis shows different time points, from 02 to 1.4. The results indicate which treatment (spironolactone or placebo) was found to be "better" for the specific subgroup being analyzed.*

Chemical Structure - spironolactone structure image

Chemical Structure - spironolactone structure image

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.